Latest news with #TrueCorporation
The Star
23-05-2025
- Business
- The Star
Thai telecom giant True faces major trust test after nationwide network outage
BANGKOK: On Thursday (May 22) morning, users of the True Corporation Plc's network across Thailand experienced a sudden and widespread service outage, affecting both mobile phone and home internet services in several areas. The outage, which continued into the afternoon, caused major disruptions to work, communications, and online transactions. The hashtag #ทรูล่ม (True down) quickly began trending on social media, reflecting not just a technical failure but a growing crisis of confidence for one of Thailand's largest telecom providers. True Corporation and Total Access Communication (DTAC) had previously completed Southeast Asia's largest telecom merger, forming a combined market capitalization of approximately 294 billion baht. At the time, True's top executives promised that the merger would create "endless opportunities" and immediate benefits for customers of both networks. True positioned itself as a network leader, aiming to cover 98% of the Thai population with 5G by 2026, while continuing nationwide network expansion. The merged entity officially registered under the name True Corporation Public Company Limited on March 1, 2023. This week marks the second anniversary of the merger. Sigve Brekke, Group CEO of True Corporation, stated that the company has allocated a 28- to 30-billion-baht budget for network expansion in 2025. "Two years into the merger, we have seen the combined strength of the two organizations drive solid and sustainable growth," he said. True has now laid out three core missions: Building a trusted brand, developing AI innovations for all Thais, and fostering a customer-centric organisational culture. 'True has become a dominant player in Thailand's telecommunications market — both in mobile and broadband. My goal is to make True a trusted and loved brand for everyone,' Brekke added. - The Nation/ANN
Yahoo
01-05-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 31%
As trade tensions between the U.S. and China show signs of easing, Asian markets are experiencing a period of cautious optimism, with investors eyeing potential opportunities amid evolving economic policies and regional developments. In this context, identifying undervalued stocks becomes crucial as investors seek to capitalize on perceived discounts in the market. Name Current Price Fair Value (Est) Discount (Est) Ningbo Sanxing Medical ElectricLtd (SHSE:601567) CN¥25.60 CN¥50.19 49% Alexander Marine (TWSE:8478) NT$142.00 NT$280.34 49.3% Wuxi Lead Intelligent EquipmentLTD (SZSE:300450) CN¥19.92 CN¥39.10 49.1% Rakus (TSE:3923) ¥2154.50 ¥4285.76 49.7% Jiangshan Oupai Door Industry (SHSE:603208) CN¥14.06 CN¥27.47 48.8% Newborn Town (SEHK:9911) HK$8.17 HK$16.06 49.1% Beijing Zhong Ke San Huan High-Tech (SZSE:000970) CN¥10.50 CN¥20.76 49.4% Tonghua Dongbao Pharmaceutical (SHSE:600867) CN¥7.23 CN¥14.11 48.8% China Ruyi Holdings (SEHK:136) HK$2.04 HK$4.07 49.9% Everest Medicines (SEHK:1952) HK$49.25 HK$96.84 49.1% Click here to see the full list of 275 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Overview: True Corporation Public Company Limited, along with its subsidiaries, offers telecommunications and value-added services in Thailand with a market cap of THB418.08 billion. Operations: The company generates revenue through its segments, including Mobile services at THB171.28 billion, Broadband Internet and Others at THB27.74 billion, and Pay TV services at THB7.00 billion. Estimated Discount To Fair Value: 20.9% True Corporation is trading at 20.9% below its estimated fair value of THB15.3, suggesting potential undervaluation based on cash flows. Despite a current net loss of THB10.97 billion for 2024, the company is forecasted to become profitable within three years with significant earnings growth expected annually at over 75%. Recent leadership restructuring aims to bolster its core digital and enterprise sectors, potentially enhancing future financial performance despite anticipated revenue declines of 0.2% per year. Our earnings growth report unveils the potential for significant increases in True Corporation's future results. Dive into the specifics of True Corporation here with our thorough financial health report. Overview: Eastroc Beverage(Group) Co., Ltd. is involved in the research, development, production, and sales of beverages in China with a market cap of CN¥148.72 billion. Operations: The company generates revenue of CN¥17.20 billion from the production, sales, and wholesale of beverages and pre-packaged foods in China. Estimated Discount To Fair Value: 22% Eastroc Beverage(Group) is trading at 22% below its estimated fair value of CNY 366.82, indicating potential undervaluation based on cash flows. The company reported strong financial performance with Q1 2025 net income rising to CNY 980.01 million from CNY 663.88 million a year ago, driven by robust revenue growth. Despite an unstable dividend track record, Eastroc's earnings are forecasted to grow significantly over the next three years, outpacing market expectations for revenue growth. In light of our recent growth report, it seems possible that Eastroc Beverage(Group)'s financial performance will exceed current levels. Take a closer look at Eastroc Beverage(Group)'s balance sheet health here in our report. Overview: Zhejiang Tianyu Pharmaceutical Co., Ltd. is involved in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs both in China and internationally, with a market cap of CN¥7.66 billion. Operations: The company generates revenue through the production and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for both domestic and international markets. Estimated Discount To Fair Value: 31% Zhejiang Tianyu Pharmaceutical is trading at 31% below its estimated fair value of CNY 32.27, highlighting its potential undervaluation based on cash flows. The company reported a significant rise in Q1 2025 net income to CNY 86.18 million from CNY 40.52 million the previous year, reflecting strong earnings growth prospects over the next three years that surpass market averages. Despite slower revenue growth forecasts compared to earnings, profitability improvements are evident. Insights from our recent growth report point to a promising forecast for Zhejiang Tianyu Pharmaceutical's business outlook. Unlock comprehensive insights into our analysis of Zhejiang Tianyu Pharmaceutical stock in this financial health report. Navigate through the entire inventory of 275 Undervalued Asian Stocks Based On Cash Flows here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SET:TRUE SHSE:605499 and SZSE:300702. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
